Post-approval studies (Phase 4)Study completedNCT00555438
What this trial is testing
Prospective, Multicentre, Open-label Study Evaluating 1.5 mg/Day of Fondaparinux.
Who this might be right for
Major Orthopaedic Surgery and Renal Impairment
Centre Hospitalier Universitaire de Saint Etienne 451